Cerebrospinal fluid rhinorrhea
Conditions
Interventions
Observation group:None
Sponsors
Beijing Tiantan Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients who underwent endoscopic endonasal skull base surgery in the Third Ward of Neurosurgery during the period from January 2021 to December 2024, with a minimum postoperative follow-up of 3 months. 2.Patients who signed the informed consent form and agreed to participate in data collection.
Exclusion criteria
Exclusion criteria: 1.Patients with preoperative cerebrospinal fluid (CSF) leakage. 2.Patients with severe comorbidities that may affect postoperative recovery or data integrity (e.g., severe cardiac, hepatic, or renal insufficiency, malignancies, etc.). 3.Patients who were lost to follow-up. 4.Patients who failed to sign the informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The proportion of patients with postoperative cerebrospinal fluid (CSF) leakage.;BMI; | — |
Secondary
| Measure | Time frame |
|---|---|
| The therapeutic efficacy for cerebrospinal fluid (CSF) leakage.;Postoperative recovery;age;Weight;Gender;History of hypertension;History of diabetes mellitus;History of heart disease;Smoking history;Drinking history;Imaging examination results;Blood indicators;Surgery type;Intraoperative skull base reconstruction technique used;Surgery duration;Intraoperative blood loss;Length of postoperative hospital stay;Time of onset of postoperative cerebrospinal fluid leakage;Symptoms of postoperative cerebrospinal fluid leakage;Imaging diagnosis of postoperative cerebrospinal fluid leak;Postoperative management measures;Postoperative complications; | — |
Countries
China
Contacts
Public ContactLei Cao
Beijing Tiantan Hospital, Capital Medical University
Outcome results
None listed